skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

Gribben, John G ; Fowler, Nathan ; Morschhauser, Franck

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2803-2811 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil

Herbaux, Charles ; Merryman, Reid ; Devine, Steven ; Armand, Philippe ; Houot, Roch ; Morschhauser, Franck ; Haverkos, Bradley

Blood, 2018-07, Vol.132 (1), p.9-16 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study
Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

Morschhauser, Franck Andre ; Cartron, Guillaume ; Thieblemont, Catherine ; Solal-Céligny, Philippe ; Haioun, Corinne ; Bouabdallah, Reda ; Feugier, Pierre ; Bouabdallah, Krimo ; Asikanius, Elina ; Lei, Guiyuan ; Wenger, Michael ; Wassner-Fritsch, Elisabeth ; Salles, Gilles Andre

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2912-2919 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study

Abramson, Jeremy S. ; Solomon, Scott R. ; Arnason, Jon ; Johnston, Patrick B. ; Glass, Bertram ; Bachanova, Veronika ; Ibrahimi, Sami ; Mielke, Stephan ; Mutsaers, Pim ; Hernandez-Ilizaliturri, Francisco ; Izutsu, Koji ; Morschhauser, Franck ; Lunning, Matthew ; Crotta, Alessandro ; Montheard, Sandrine ; Previtali, Alessandro ; Ogasawara, Ken ; Kamdar, Manali

Blood, 2023-04, Vol.141 (14), p.1675-1684 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Wang, Michael ; Rule, Simon ; Zinzani, Pier Luigi ; Goy, Andre ; Casasnovas, Olivier ; Smith, Stephen D ; Damaj, Gandhi ; Doorduijn, Jeanette ; Lamy, Thierry ; Morschhauser, Franck ; Panizo, Carlos ; Shah, Bijal ; Davies, Andrew ; Eek, Richard ; Dupuis, Jehan ; Jacobsen, Eric ; Kater, Arnon P ; Le Gouill, Steven ; Oberic, Lucie ; Robak, Taduesz ; Covey, Todd ; Dua, Richa ; Hamdy, Ahmed ; Huang, Xin ; Izumi, Raquel ; Patel, Priti ; Rothbaum, Wayne ; Slatter, J Greg ; Jurczak, Wojciech

The Lancet (British edition), 2018-02, Vol.391 (10121), p.659-667 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Dreyling, Martin ; Santoro, Armando ; Mollica, Luigina ; Leppä, Sirpa ; Follows, George A ; Lenz, Georg ; Kim, Won Seog ; Nagler, Arnon ; Panayiotidis, Panayiotis ; Demeter, Judit ; Özcan, Muhit ; Kosinova, Marina ; Bouabdallah, Krimo ; Morschhauser, Franck ; Stevens, Don A ; Trevarthen, David ; Giurescu, Marius ; Cupit, Lisa ; Liu, Li ; Köchert, Karl ; Seidel, Henrik ; Peña, Carol ; Yin, Shuxin ; Hiemeyer, Florian ; Garcia-Vargas, Jose ; Childs, Barrett H ; Zinzani, Pier Luigi

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3898-3905 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Walter, Harriet S. ; Rule, Simon A. ; Dyer, Martin J.S. ; Karlin, Lionel ; Jones, Ceri ; Cazin, Bruno ; Quittet, Philippe ; Shah, Nimish ; Hutchinson, Claire V. ; Honda, Hideyuki ; Duffy, Kevin ; Birkett, Joseph ; Jamieson, Virginia ; Courtenay-Luck, Nigel ; Yoshizawa, Toshio ; Sharpe, John ; Ohno, Tomoya ; Abe, Shinichiro ; Nishimura, Akihisa ; Cartron, Guillaume ; Morschhauser, Franck ; Fegan, Christopher ; Salles, Gilles

Blood, 2016-01, Vol.127 (4), p.411-419 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

COIFFIER, Bertrand ; PRO, Barbara ; PINTER-BROWN, Lauren ; PADMANABHAN, Swaminathan ; SHUSTOV, Andrei ; NICHOLS, Jean ; CARROLL, Susan ; BALSER, John ; BALSER, Barbara ; HORWITZ, Steven ; PRINCE, H. Miles ; FOSS, Francine ; SOKOL, Lubomir ; GREENWOOD, Matthew ; CABALLERO, Dolores ; BORCHMANN, Peter ; MORSCHHAUSER, Franck ; WILHELM, Martin

Journal of clinical oncology, 2012-02, Vol.30 (6), p.631-636 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma

Herbaux, Charles ; Gauthier, Jordan ; Brice, Pauline ; Drumez, Elodie ; Ysebaert, Loic ; Doyen, Hélène ; Fornecker, Luc ; Bouabdallah, Krimo ; Manson, Guillaume ; Ghesquières, Hervé ; Tabrizi, Reza ; Hermet, Eric ; Lazarovici, Julien ; Thiebaut-Bertrand, Anne ; Chauchet, Adrien ; Demarquette, Hélène ; Boyle, Eileen ; Houot, Roch ; Yakoub-Agha, Ibrahim ; Morschhauser, Franck

Blood, 2017-05, Vol.129 (18), p.2471-2478 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Vercellino, Laetitia ; Cottereau, Anne-Segolene ; Casasnovas, Olivier ; Tilly, Hervé ; Feugier, Pierre ; Chartier, Loic ; Fruchart, Christophe ; Roulin, Louise ; Oberic, Lucie ; Pica, Gian Matteo ; Ribrag, Vincent ; Abraham, Julie ; Simon, Marc ; Gonzalez, Hugo ; Bouabdallah, Reda ; Fitoussi, Olivier ; Sebban, Catherine ; López-Guillermo, Armando ; Sanhes, Laurence ; Morschhauser, Franck ; Trotman, Judith ; Corront, Bernadette ; Choufi, Bachra ; Snauwaert, Sylvia ; Godmer, Pascal ; Briere, Josette ; Salles, Gilles ; Gaulard, Philippe ; Meignan, Michel ; Thieblemont, Catherine

Blood, 2020-04, Vol.135 (16), p.1396-1405 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (636)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (642)
  2. Anais de Congresso  (5)
  3. Reports  (2)
  4. Book Chapters  (2)
  5. Videos  (1)
  6. Dissertações  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2003  (5)
  2. 2003Até2007  (35)
  3. 2008Até2012  (87)
  4. 2013Até2018  (199)
  5. Após 2018  (327)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (637)
  2. Japonês  (33)
  3. Francês  (23)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.